Research Article

Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis

Table 3

Basic information of AP’s potential ingredients.

DrugMolecule nameMolIDOBDL

HuangqiMairinMOL00021155.380.78
HuangqiJaranolMOL00023950.820.29
HuangqiHederageninMOL00029636.910.75
Huangqi(3S,8S,9S,10 R,13R,14S,17R)-10,13-dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-olMOL00003336.230.78
HuangqiIsorhamnetinMOL00035449.60.31
Huangqi3,9-Di-O-methylnissolinMOL00037153.740.48
Huangqi7-O-MethylisomucronulatolMOL00037874.690.3
Huangqi(6aR,11aR)-9,10-dimethoxy-6a,11a-dihydro-6H-benzofurano[3,2-c]chromen-3-olMOL00038064.260.42
HuangqiBifendateMOL00038731.10.67
HuangqiFormononetinMOL00039269.670.21
HuangqiCalycosinMOL00041747.750.24
HuangqiKaempferolMOL00042241.880.24
HuangqiFAMOL00043368.960.71
Huangqi(3R)-3-(2-Hydroxy-3,4-dimethoxyphenyl)chroman-7-olMOL00043867.670.26
HuangqiQuercetinMOL00009846.430.28
NiuxiPoriferasta-7,22E-dien-3beta-olMOL00100642.980.76
Niuxiβ-EcdysteroneMOL01254244.230.82
NiuxiBerberineMOL00145436.860.78
NiuxiCoptisineMOL00145830.670.86
NiuxiWogoninMOL00017330.680.23
NiuxiDelta 7-stigmastenolMOL00264337.420.75
NiuxiBaicaleinMOL00271433.520.21
NiuxiBaicalinMOL00277640.120.75
NiuxiEpiberberineMOL00289743.090.78
NiuxiBeta-sitosterolMOL00035836.910.75
NiuxiInophyllum EMOL00384738.810.85
KunbuCLRMOL00095337.870.68
KunbuSaringosterolMOL01061543.480.62
Kunbu24-MethylenecholesterolMOL01062543.540.76
KunbuFucosterolMOL00962243.780.76
Kunbu1553-41-9MOL01061745.660.21
KunbuEckolMOL01061687.060.63
DangguiStigmasterolMOL00044943.830.76
SanqiMandenolMOL001494420.19
SanqiDFVMOL00179232.760.18
SanqiDiopMOL00287943.590.39
SanqiGinsenoside rh2MOL00534436.320.56